Medical specialist practice in FR. Official registry identity, filed financial evidence and a public indicative value curve on one indexed company profile.
Historical rounded range based on the latest available public filing for fiscal year 2018. This is not a current market value or asking price.
Based on filed company accountsThe historical value curve is public. Create a free account for the future five-year growth outlook, the insights behind it, and concrete action points that can increase this company’s value.
Free account · private workspace
Each step adds evidence that narrows the range. Public filings are a starting point. Connected accounts, owner context and method review make the valuation more useful for real decisions.
Own this company? Claim and manage the profileYou have seen the historical curve. Create a free account to explore a private five-year value scenario and the assumptions behind it.
The historical indicative range for DOCTEUR FRANCIS DUBOSQ uses the latest available public filing and sector calibration. It is not a current market value or asking price; current owner or advisor data is needed for a full valuation.
Express interest and ask Upswitch to discreetly sound out the owner. We review every request before making contact.
This is an estimate, not an asking price. It is based on dated public sources and is not an owner forecast, offer, investment advice, or confirmation that the company is for sale.
Request verified control to add current figures, improve the profile and manage what happens next. We verify ownership before granting access.
DOCTEUR FRANCIS DUBOSQ is a medical specialist practice based in France. The company was founded in 2013, incorporated as a 5485.
DOCTEUR FRANCIS DUBOSQ is listed in French National Business Register (RNE/INPI) under registry number 793861584. The public employee band is 01, a useful triage field for banks, credit analysts, and M&A acquirers. This profile consolidates official annual accounts into one indexable company dossier.
Companies in this NACE 86.22 band file annual accounts with INPI.
Across the 2016-2018 window revenue has stayed broadly flat, moving from €612,828 to €661,819.
The most recent annual filing covers 2018 (period end 2018-12-31).
If you are researching DOCTEUR FRANCIS DUBOSQ for acquisition, investment, or due-diligence purposes, this page consolidates its firmographics, multi-year filings, and a historical indicative range based on the latest available public filing, not a current market value.
Public regulator-filed figures across 3 years.
Fiscal year | Revenue | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 201831 Dec 2018 | €661,819 | - | €396,652 | €173,836 | - |
| 201731 Dec 2017 | €643,116 | - | €481,770 | €219,879 | - |
| 201631 Dec 2016 | €612,828 | - | €294,932 | €209,023 | - |
DOCTEUR FRANCIS DUBOSQ was founded in 2013 and is registered with French National Business Register (RNE/INPI), incorporated as a 5485.
DOCTEUR FRANCIS DUBOSQ is registered under NACE 86.22: NACE 86.22. That places the business within the French cluster for this activity.
The most recently filed annual accounts cover fiscal year 2018 (period end 2018-12-31), publicly available via French National Business Register (RNE/INPI).
This page shows a rounded historical indicative range for DOCTEUR FRANCIS DUBOSQ, based on the latest available public filing for fiscal year 2018. It is not a current market value, asking price, certified or statutory valuation, or financial, investment, tax or legal advice. Verify current figures before relying on it for any decision or transaction.
Company identity and public facts are reused from the official or licensed source named on this page, with its filing or update date. Upswitch estimates remain distinct from source facts and do not imply endorsement by the registry. Natural-person enterprises are excluded from public valuation pages, and public registry personal data is not used for direct marketing.
Connected to this company and want something corrected? Request a correction or removal · Privacy policy · Terms & conditions · Data sources & evidence
